HEALTH (MSM)

Jurors begin deliberating in Colorado movie massacre trial

By Keith Coffman DENVER (Reuters) – Jurors in Colorado’s movie massacre trial began deliberating on Wednesday on the fate of gunman James Holmes, who has pleaded not guilty by reason of insanity to multiple counts of murder and attempted murder stemming from the July 2012 rampage. Holmes, a 27-year-old former neuroscience graduate student from California, could face the death penalty if he is convicted of opening fire inside a midnight

Revolutionary Way to Be Healthy #10: See the Bigger Picture

Typically, when we want to check our health and fitness progress, we step on the scale or look in the mirror. But when it comes to well-being, what you see isn’t always what you get — or at least, not all that you get.We’ve been inclined to believe that pursuing health and fitness is predominantly self-focused, and that we alone stand to…

Burkina Faso presidential hopefuls urged to tackle early, forced marriage

By Kieran Guilbert LONDON (Thomson Reuters Foundation) – Burkina Faso’s presidential candidates must commit to tackling forced and early marriage and improving access to contraception, sex education and health services for women and girls ahead of elections in October, a rights group said on Wednesday. While gender equality is protected under the country’s constitution and law, widespread forced and early marriage and unwanted pregnancies have reduced hundreds of thousands of

Marrying Health and Human Rights: How LGBT Health and Population Health Will Improve Because of Marriage Equality

In ruling that the 14th Amendment requires states to issue marriage licenses to same-sex couples and recognize same-sex marriages performed in other states, the U.S. Supreme Court, in Obergefell vs. Hodges, not only addressed a fundamental issue of equality, but may have unwittingly contributed to improved public health.Consider the research…

Johnson & Johnson second-quarter sales wilt on strong dollar, weak device sales

Johnson & Johnson on Tuesday reported sharply lower sales in the second quarter, and cited a stronger U.S. dollar, disappointing sales of its medical devices and plunging demand for a hepatitis C drug faced with strong competition. J&J Chief Executive Alex Gorsky acknowledged that sales of medical devices, one of the company’s big three product lines, have disappointed in recent quarters, but in a conference call, he urged industry analysts